Page last updated: 2024-10-28

gossypol and Squamous Cell Carcinoma of Head and Neck

gossypol has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies

Gossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
" For the pharmacokinetic analysis, plasma AT-101 levels were measured by HPLC in blood samples collected from patients enrolled in our clinical phase I/II study."2.80Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer. ( Dubbelman, R; Hoebers, FJ; Kuipers, GK; Lafleur, MV; Slotman, BJ; Stoter, TR; van den Brekel, MW; Verheij, M; Zerp, SF, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Melo, G1
Silva, CAB1
Hague, A1
Parkinson, EK1
Rivero, ERC1
Zerp, SF1
Stoter, TR1
Hoebers, FJ1
van den Brekel, MW1
Dubbelman, R1
Kuipers, GK1
Lafleur, MV1
Slotman, BJ1
Verheij, M1

Reviews

1 review available for gossypol and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
    Oral oncology, 2022, Volume: 132

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gossypol; Head and Neck Neoplasms; Humans; Proto

2022

Trials

1 trial available for gossypol and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
    Radiation oncology (London, England), 2015, Jul-30, Volume: 10

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line

2015